Is topical roflumilast set to become a dermatological panacea?
Hospital Pharmacy Europe
JUNE 19, 2023
Topical roflumilast is being increasingly trialled for a number of skin conditions but how effective is it, and will it take centre stage in the field of dermatology? PDE4 inhibitors have become a promising class of drugs with a potential role in a number of therapy areas such as pulmonary, dermatological and neurological diseases.
Let's personalize your content